In licensing for Chinese market
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
16
NCT04798781
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
Phase: Phase 2
Role: Collaborator
Start: Jul 28, 2021
Completion: Feb 14, 2026
Loading map...